ArticleBMC pulmonary medicine2026
Comparative effectiveness of video-assisted thoracoscopic surgery versus open thymectomy for thymoma: a propensity score-matched analysis of 317 patients.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAlthough video-assisted thoracic surgery (VATS) thymectomy has been widely adopted for thymoma resection, its comparative effectiveness versus open approaches (thoracotomy and sternotomy) remains controversial. This study aimed to comprehensively evaluate perioperative and long-term outcomes among these surgical modalities.
methodsIn this retrospective cohort study, 317 consecutive patients with pathologically confirmed thymoma underwent surgical resection at Beijing Chest Hospital (2005-2024). Patients were stratified by approach: VATS (n = 178), unilateral thoracotomy (n = 73), and median sternotomy (n = 66). Propensity score weighting (PSW) was applied to balance baseline covariates. Primary endpoints included intraoperative metrics (blood loss, operative time), postoperative recovery (chest tube duration, hospital stay), and oncologic outcomes (recurrence-free survival [RFS], overall survival [OS]).
resultsIntraoperative Outcomes: Sternotomy demonstrated significantly longer operative time (median 138.0 [IQR 120-180] vs. 100.0 [75.4-150.7] vs. 120.0 [90-150] minutes; P = 0.008) and greater blood loss (median 291.5 [200-403] vs. 100.0 [50-200] vs. 50.0 [50-100] mL; P < 0.001) compared to thoracotomy and VATS, respectively. Postoperative Outcomes: Sternotomy required higher postoperative pleural drainage volume (median 848.4 [620-1524.7] vs. 632.9 [450-1020] vs. 540.0 [340-742.2] ml; P = 0.002) and extended hospitalization (median 14.0 [11-19.5] vs. 9.16 [8-14] vs. 9.0 [7-13] days; P < 0.001). Survival Analysis: Multivariable Cox models revealed no statistically significant differences were observed in OS (thoracotomy vs. VATS: HR = 2.44, 95% CI 0.70-8.42, P = 0.158; sternotomy vs. VATS: HR = 1.89, 95% CI 0.45-7.48, P = 0.361) or RFS (thoracotomy HR = 0.56, 95% CI 0.16-1.94; sternotomy HR = 0.74, 95% CI 0.16-3.37) across approaches (all P > 0.05). Advanced Masaoka-Koga stage (III/IV) independently predicted worse OS (HR = 2.88, 95% CI 1.13-7.33, P = 0.027).
conclusionPreliminary evidence showed that VATS provided short-term superior perioperative outcomes with significantly less blood loss and shorter hospital stays compared to sternotomy, while maintaining comparable long-term survival across surgical approaches. Given the retrospective nature and methodological limitations of this study, these observations require rigorous confirmation through prospective multicenter studies to establish evidence-based guidelines for surgical approach selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.